Skip to main content
. 2017 Nov 24;53(2):181–196. doi: 10.1007/s00535-017-1414-2

Table 1.

Pathological classification of NAFLD for diagnosis and evaluation of disease severity

References Type Description Diagnosis of NASH
Matteoni [15] Diagnosis Type 1 (steatosis)
Type 2 (steatosis + lobular inflammation)
Type 3 (steatosis + ballooning)
Type 4 (steatosis + fibrosis or steatosis + MDB)
Type 3 and 4
Brunt [20] Severity Grade (activity) 1–3
Stage (fibrosis) 1–4a
Not for diagnosis
NAFLD activity score (NAS) [21] Diagnosis Steatosis 0–3
Inflammation 0–3
Ballooning 0–3
Total score is 5 (4) or higher than 5 (4)
Younossi [23] Diagnosis (1) Steatosis + centrilobular ballooning and/or MDB
(2) Steatosis + centrilobular pericellular/perisinusoidal fibrosis or bridging fibrosis
(1) or (2)

MDB Mallory–Denk bodies

a Stage 1 was particularly classified by Kleiner et al. as a part of NAS (delicate perisinusoidal fibrosis in the perivenular area as 1A, dense perisinusoidal fibrosis in the perivenular area as 1B and detection of portal fibrosis without perisinusoidal fibrosis was defined as 1C.)